Participants may access the complete program - including keynote sessions, scientific presentations, schedules, and important logistical information.
We invite all attendees to review the final program and prepare for an engaging and insightful conference. We look forward to welcoming you to ICPCos 2025.
Event Details
Date: 3 December 2025 at 9:00 am – 4 December 2025 at 5:00 pm
Venue: Monash University Malaysia - Jalan Lagoon Selatan, 47500 Bandar Sunway, Selangor Darul Ehsan. - Maps & Transport *The closest BRT station (directly connected to the campus) is SunU - Monash. The SunU - Monash BRT station is on the Sunway BRT line (connected to the LRT Kelana Jaya line through the interchange station USJ 7)
Registration Fees (including daily lunches and teas) :
Early Bird Registration(on or before 3 October 2025) : RM450 (Student), RM600 (Others)
Standard Registration(after 3 October 2025) : RM600 (Student), RM900 (Others) *10% discount for group registration of 5 participants or above
The 2nd International Conference in Pharmaceutics and Cosmetics (ICPCos 2025) aims to create a vibrant platform for knowledge exchange and collaboration among academics, researchers, industry professionals, and entrepreneurs. Building on the success of the inaugural conference, ICPCos 2025 will spotlight cutting-edge advancements in pharmaceutical and cosmetic sciences, with a focus on their applications for industrial innovation and societal benefit.
Unlock Professional Growth: This conference is accredited by the Malaysian Pharmacists Society for CPD points.
Earn 14 CPD points under Category A1 by attending!
Conference Objectives:
Foster Academic-Industrial Collaboration: Strengthen partnerships between academia and the pharmaceutical and cosmetics industries to translate research innovations into practical solutions.
Encourage Academic Entrepreneurship: Inspire and support entrepreneurial initiatives among academics, fostering the development of novel products and technologies.
Highlight Technological Advancements: Showcase recent advances in pharmaceutical and cosmetic technologies, emphasizing their potential impact on industrial growth and development.
Key Activities
Plenary and Keynote Sessions: Insights from leading experts on emerging trends and groundbreaking innovations in pharmaceutics and cosmetics.
Scientific Presentations: Oral and poster sessions featuring the latest research findings and case studies.
Industry Showcases and Exhibitions: Opportunities for industry leaders and startups to present their products, technologies, and services.
Networking Opportunities: Dedicated sessions to connect participants, fostering collaborations across academia and industry.
Call for Abstracts
We invite researchers, academics, and industry professionals to submit abstracts for oral or poster presentations. Abstracts should highlight significant and original contributions within the scope of pharmaceutical and cosmetic sciences.
Publication Opportunities
Special Issue Partnership
Conference abstracts eligible for consideration in the special issue of Advances in Pharmacological and Pharmaceutical Sciences (Wiley Journal)
FREE Publication Fee Waiver for up to Three selected accepted papers
Enhance your academic profile with peer-reviewed publications
Student Awards & Recognition
Outstanding Presentation Awards
Oral Presentation Category
First Prize: MYR 300 Cash Prize + Certificate
Second Prize: MYR 200 Cash Prize + Certificate
Third Prize: MYR 100 Cash Prize + Certificate
Poster Presentation Category
First Prize: MYR 150 Cash Prize + Certificate
Second Prize: MYR 100 Cash Prize + Certificate
Third Prize: MYR 50 Cash Prize + Certificate
Abstract Submission Guidelines
Deadline for Submission: 3 October 2025
Abstract Format:
Word Count: 300 words maximum (excluding title, author names)
Format Requirements:
Title: Bold, 14-point font, maximum 15 words
Author Information: (12-point font): Presenter’s Name (first), followed by other authors’ names
Affiliation(s): Institution(s) of all authors (12-point font)
Abstract Body: 12-point font, structured as follow:
Purpose
Methods
Results
Conclusion
Preferred Presentation Format: Oral or Poster (please indicate preference). The organising committee reserves the right to make the final decision regarding allocation to oral or poster presentation.
Topic Areas: Please select one of the following areas as the nature of the presentation.
Cosmetic Science
Pharmaceutical Technology
Pharmaceutical/Biomedical Analysis
Biomedical Sciences
Note: Provisional abstract acceptance will be notified within 1 month after submission. Final abstract acceptance will only be confirmed after registration has been submitted.
Professor Giorgia Pastorin, Department of Pharmacy and Pharmaceutical Science, National University of Singapore
Title: Development of New and Safer Derivatives of Para-Phenylene Diamine as Permanent Hair Dyes
Professor Giorgia Pastorin, a registered Pharmacist from Italy, earned her Ph.D. in Pharmaceutical Chemistry from the University of Trieste in 2004. Following a postdoctoral position at CNRS in France, she joined the National University of Singapore (NUS) as an Assistant Professor in 2006, advancing to Associate Professor in 2011 and full Professor in 2024. Her leadership roles at NUS have included Assistant and Deputy Head of the Department of Pharmacy, Director of the Pharmaceutical Innovation and Research Center (PIRC), and Assistant Dean for Research & Development in the Faculty of Science (2017-2024). In July 2024, she was appointed Head of the Department of Pharmacy & Pharmaceutical Sciences. Professor Pastorin's research focuses on cell-derived nanovesicles (CDNs) as biocompatible, targeted drug delivery systems. For her contributions in BioNano-Technology, she received the Young Scientist Award (2015). She has edited two books on drug delivery and authored over 140 articles in peer-reviewed journals.
Professor Tin Wui Wong, Faculty of Pharmacy and Smart Manufacturing Research Institute, Universiti Teknologi MARA
Title: Polysaccharides and Cancer Nanomedicine Development
Professor Wong Tin Wui is a renowned pharmaceutical researcher with a PhD from the National University of Singapore (1999). He is a lecturer and principal fellow at UiTM's Faculty of Pharmacy and Smart Manufacturing Research Institute, specializing in precision nanodrug delivery for oral, skin, and pulmonary applications. With over 135 peer-reviewed publications, he holds editorial roles at several journals, including *Asian Journal of Pharmaceutical Sciences* and *Drug Development and Industrial Pharmacy*. Dr. Wong founded the Non-Destructive Biomedical and Pharmaceutical Research Centre in Malaysia and co-founded the Sino-Malaysia Molecular Oncology and Traditional Chinese Medicine Delivery Joint Research Centre at Yangzhou University. He is a jury member for the Maurice-Marie Janot Award and founded the Malaysia Technology Expo Sustainable Development Goals International Innovation Awards. His academic influence spans Asia as a visiting/adjunct professor at institutions like the National University of Singapore, Yangzhou University, and Chulalongkorn University. He is also a fellow of the Academy of Sciences Malaysia.
Associate Professor Jittima Amie Luckanagul, Faculty of Pharmaceutical Science, Chulalongkorn University
Title: Novel Biopolymers and Their Combinatorial Nano-Assemblies as Innovative Functional Cosmetic Ingredients.
Associate Professor Jittima Amie Luckanagul holds a B.Sc. in Pharmacy from Chulalongkorn University (2008) and a Ph.D. in Chemistry and Biochemistry from the University of South Carolina, USA (2014), where she also worked as a postdoctoral fellow. Since joining Chulalongkorn University’s Faculty of Pharmaceutical Sciences in 2016, she has served as Associate Dean for Global Engagement and International Affairs (2021-2024) and, as of May 2024, Acting Assistant to the President for International Affairs, Innovation, and Global Engagement, driving cross-border collaborations and the university’s global research presence. An expert in hyaluronic acid, polymer science, drug delivery, and vaccine stabilization, Associate Professor Luckanagul is a sought-after panelist at international forums, including the APRU APEC University Leaders' Forum 2022 and the SelectUSA Investment Summit 2023. Her leadership extends to innovation organizations, and her contributions have earned her accolades such as the Outstanding Professor in Innovation, ASAIHL Thailand Outstanding Achievement Award 2023, and Outstanding Pharmacist Award (Early Career) 2023.
Associate Professor Alice Chuah Lay Hong, School of Pharmacy, Monash University Malaysia
Title: Pathways to Repair: Bridging Biology and Innovation
Associate Professor Alice Chuah holds an MPharm from the University of Strathclyde and a PhD in Pharmacy from the University of Nottingham. She began her academic career as a Lecturer at Monash University Malaysia, where she advanced to Senior Lecturer and now serves as Associate Professor. A prolific researcher, she has published extensively in high-impact journals and contributed to several book chapters. Her scientific excellence has earned her recognition as one of Stanford/Elsevier’s Top 2% Scientists in the world. Among her accolades are the APEC-Australia Women in Research Fellowship, the Malaysia National Cancer Council Cancer Research Award, and the World Federation of Scientists Scholarship. Her innovative work in drug delivery and formulation has led to several international and national invention awards, and she holds multiple patents. Currently, she serves as the Focus Group Leader for Wound & Dermal Delivery in the Controlled Release Society (Malaysia Chapter). Her research interests focus on advanced drug delivery systems, particularly nanoparticles and wound dressings.
Speakers
Dr. Usha Sundralingam, School of Pharmacy, Monash University Malaysia
Title: A Sustainable Plant-Based Nanoformulation for Skin Rejuvenation and Barrier Repair
Dr. Usha is a formulation scientist and cosmetic chemist with expertise in pharmaceutical and cosmeceutical product development. Her research focuses on natural product-based formulations, including nano-phytosomes, lipid-based drug delivery systems, and geroprotective skincare. She is also involved in the sustainable bioproduction of high-value bioactives, particularly urolithins, through microbial biotransformation of ellagitannin-rich fruit waste. Her work aims to harness locally sourced agricultural byproducts to generate bioactive metabolites with anti-aging and therapeutic potential, contributing to a more sustainable and cost-effective approach for pharmaceutical and cosmeceutical applications. Dr. Usha has collaborated on advanced drug delivery systems and is actively engaged in education and industry outreach. She has received multiple accolades for her contributions to teaching and community engagement in pharmaceutical sciences.
Dr. Ronald Lee, School of Pharmacy, Monash University Malaysia
Title: Imaging Mass Spectrometry to Uncover the In Vitro Distribution of Ruthenium and Platinum Anti-Cancer Complexes
Dr. Ronald Lee is a Senior Lecturer at Monash University Malaysia, specializing in analytical chemistry. He obtained his Bachelor of Science (Pharmacy) from the National University of Singapore and is a registered pharmacist. He later completed his PhD at the École Polytechnique Fédérale de Lausanne, where he specialised in mass spectrometry applications to study drug interactions. His research spans analytical method development, natural product characterisation and formulation, with a strong focus on chromatography and mass spectrometry for bioactive compound characterisation.
Dr. Athirah Bakhtiar, School of Pharmacy, Monash University Malaysia
Title: Advancing Cancer Therapeutics: pH-Responsive Inorganic Nanoparticles for Gene Delivery
Dr. Athirah Bakhtiar is a Senior Lecturer and BPharm Coordinator at the School of Pharmacy, Monash University Malaysia, specializing in medical nanotechnology for advanced drug and gene delivery systems. Her research focuses on the development of biodegradable and inorganic nanomaterials to enhance the targeted delivery of therapeutics, particularly for cancer and non-communicable diseases. She explores stimuli-responsive nanoparticles, RNA-based therapies, and bioengineered delivery platforms to improve cellular uptake, therapeutic efficacy, and precision medicine applications. Supported by national and international research grants, her work is widely published in high-impact journals and has been recognized with multiple national and international awards. An active member of global pharmaceutical and biomedical organizations, she collaborates extensively on translational research bridging nanomedicine, gene therapy, and clinical applications.
Assistant Professor Romchat Chutoprapat, Faculty of Pharmaceutical Science, Chulalongkorn University
Title: Development of Brightening Serum Utilising Multi-Mechanism Active Ingredients
Dr. Romchat Chutoprapat is an Assistant Professor at the Department of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmaceutical Sciences, Chulalongkorn University, Thailand. She holds a Ph.D. in Pharmaceutical Sciences from Chiang Mai University, where her research focused on the entrapment of bioactive compounds in nanovesicles for cosmetic applications. Her research interests lie in nanotechnology and delivery systems for cosmetics and pharmaceutical products, particularly in skincare and haircare development. Dr. Romchat has published numerous articles in international journals and contributed to several major research projects, focusing on the development of topical formulations, nanovesicles, and plant-based bioactive substances. Prior to her academic career, she worked as an Innovation Senior Scientist at GlaxoSmithKline Consumer Healthcare and as a Postdoctoral Research Fellow at the National University of Singapore.
Associate Professor Varin Titapiwatanakun, Faculty of Pharmaceutical Science, Chulalongkorn University
Title: Particle Engineering for Nasal Powder Delivery
Varin Titapiwatanakun received her Ph.D. in Pharmaceutics from University College London, The School of Pharmacy and joined the Faculty of Pharmaceutical Sciences, Chulalongkorn University as a lecturer in 2016. She is currently an Associate Professor at the Department of Pharmaceutics and Industrial Pharmacy. Her research focuses on novel drug delivery system, 3D printing, cocrystallization and particle engineering. She has contributed to several industrial pharmacy research projects, collaborating with various governmental sectors including the Thai Food and Drug Administration (FDA), Thai Red Cross Plasma Fractionation Centre and Government Pharmaceutical Organization (GPO) factory. Varin is also a member of the cyclodextrin Application and Nanotechnology-based Delivery Systems Research Unit. Additionally, she received a grant from the Asia/Africa Center for Drug Discovery at Meiji Pharmaceutical University (MPU-AACDD) in Japan and was a visiting scholar at the Laboratory of Molecular Pharmaceutics under Professor Toshiro Fukami in recent years.
Associate Professor Liang Huazheng, School of Medical Sciences, Monash University Suzhou
Title: Ischemic Stroke: Regional Difference in China and Potential Emerging Therapies from the Perspective of Pericytes
Dr. Huazheng Liang graduated with a PhD from the University of New South Wales, Australia in 2012, under the supervision of Academician Professor George Paxinos. He is a lecturer in the Biotechnology department of the Southeast University-Monash University Joint Graduate School and an associate professor at the Monash University School of Medical Sciences. The main research directions are neuroanatomy and neuropharmacology. As a clinician, he pays particular attention to the traditional Chinese medicine treatment of stroke and Alzheimer's disease. He has received the Young Investigator Award of the Asia-Pacific Society of Neurochemistry, the title of Jiangsu Province's "Double Innovation Talent", and the title of Dushu Lake Young International Leader. He is the chairperson of the Suzhou Pharmaceutical and Additive Manufacturing Concept Validation Center. He has secured two seed projects of the Australian Research Council-Center of Integrative Brain Function, one discovery project of the National Natural Science Foundation of China, and participated in the National Brain Initiative of China. Ninety SCI papers have been published, among which 46 are first or corresponding papers. He is an editorial board member of the Journal of Central Nervous System Disease and Scientific Reports, and a guest editor of the Ethnopharmacology section in Frontiers in Pharmacology.
Associate Professor Lin Haishu, College of Pharmacy, Shenzhen Technology University, China
Title: Piceatannol Promotes Burn Wound Healing
Dr. Lin Haishu is a tenured Associate Professor at the College of Pharmacy, Shenzhen Technology University. He received his BSc from Sun Yat-sen University and completed his PhD at the National University of Singapore (NUS). From 2012 to 2020, he held the position of Assistant Professor in the Department of Pharmacy at NUS. Dr. Lin’s research focuses on the anti-inflammatory pharmacology and pharmacokinetics of herbal phytochemicals. He has published over 70 peer-reviewed research articles and holds an h-index of 26. In addition to his academic role, Dr. Lin serves as an Associate Editor for Frontiers in Pharmacology and is an active peer reviewer for more than 100 scientific journals.
Associate Professor Koh Hwee Ling, Department of Pharmacy and Pharmaceutical Sciences, Faculty of Science, National University of Singapore
Title: The Quest for Beauty: Inside and Outside
A/P Koh Hwee Ling is an Associate Professor at the Department of Pharmacy and Pharmaceutical Sciences at the National University of Singapore. She graduated with a PhD from the University of Cambridge (United Kingdom) and obtained an MSc and BSc (Pharmacy) from the National University of Singapore. She is a registered pharmacist and serves or has served in various international and national committees, e.g. the United States Pharmacopoeia expert panels, Ministry of Health (Singapore), Health Sciences Authority of Singapore, Singapore Food Agency etc. She is also a technical assessor with the Singapore Accreditation Council (Enterprise Singapore) and a member of the National University of Singapore Institutional Review Board Committee. She has published 4 books, namely, “Grow your own medicine. Edible healing plants in your garden”, “Ginseng and ginseng products 101: what are you buying?”, “Medicinal plants and malaria: applications, trends and prospects” and “A Guide to Medicinal Plants: an illustrated, scientific and medicinal approach”. A/P Koh has been awarded multi-international patents for “Compound for use in the treatment and/or prevention of parasitic mediated diseases”.
Professor Yuichi Tozuka, Faculty of Pharmacy, Department of Formulation Design and Pharmaceutical Sciences, Osaka Medical and Pharmaceutical University, Japan
Title: Enhancing Solubility and Bioavailability of Poorly Water-Soluble Compounds via Self-Assembled Nanocomposite Formulations
Professor Yuichi Tozuka is an expert in pharmaceutical technology, focusing on formulation strategies to improve the solubility and bioavailability of poorly water-soluble drugs. His research highlights include the use of trans-glycosylated food additives, spray-dried nanocomposites, and co-amorphous systems to enhance dissolution and absorption. He has also advanced pulmonary drug delivery through the design of inhalable powders and computational modeling of aerosol deposition. With over 200 peer-reviewed publications, his work bridges solid-state science and practical formulation design to address key challenges in modern drug delivery.
Dr Fu Ju Yen, Product Development and Advisory Department, Malaysian Palm Oil Board
Title: Clinical translation of nanostructured lipid carrier (NLC) encapsulating vitamin E tocotrienols: Phase 1 bioavailability / bioequivalence study
Dr Ju-Yen is a pharmacist with a PhD in pharmaceutical science. She has more than 10 years’ experience as a senior research scientist at the Malaysian Palm Oil Board. Her research interests focus on the application of delivery systems for bioactives using liposomes, nanoparticles and dispersion techniques. Her research also focuses on clinical translation of novel products in phase 1 and phase 2 clinical trials. She is currently leading the Nanotechnology Pilot Plant for manufacturing food grade nano-formulations. She is a member of the ISO Technical Committee on Nanotechnologies (Ministry of Science, Technology and Innovation), member of the Expert Working Committee on Nutrition, Health Claims, and Advertising (Ministry of Health, Malaysia), and the current President of the Controlled Release Society Malaysian local chapter.
Associate Professor Pang Zhiqing, Key Laboratory of Smart Drug Delivery Systems (Ministry of Education) and the National Key Laboratory of Advanced Drug Formulations Overcoming Biological Delivery Barriers, Fudan University
Title: AI-Enabled Drug Discovery and Targeted Drug Delivery
Dr Zhiqing Pang is a core faculty member of the Key Laboratory of Smart Drug Delivery Systems (Ministry of Education) and the National Key Laboratory of Advanced Drug Formulations Overcoming Biological Delivery Barriers, Fudan University, PR China. His research focuses on targeted drug delivery systems and the development of novel pharmaceutical formulations. He has published over 110 papers as the first or corresponding author in prestigious journals such as Nature Communications, Cell Reports Medicine, Nano Today, ACS Nano, Advanced Science, and Acta Pharmaceutica Sinica B, and has been repeatedly recognized as one of the top 2% most-cited scientists worldwide. Currently, he serves as Associate Editor of Frontiers in Nanotechnology, Young Editorial Board Member for Acta Pharmaceutica Sinica B, Exploration, and Asian Journal of Pharmaceutical Sciences, and Editorial Board Member for several SCI-indexed journals including Chinese Chemical Letters, Pharmaceutics, and Current Pharmaceutical Design. He has led multiple grants from the National Natural Science Foundation of China and participated as a key investigator in national major research programs and key science and technology projects. His research achievements have been honored with the First Prize of Natural Science from the Ministry of Education, China (2010), the Chinese Pharmaceutical Association–Sanofi Youth Biopharmaceutical Award (2017), and the Second Prize of the National Scientific and Technological Progress Award, China (2018).
We are honoured to host a diverse group of leading experts in the fields of pharmaceutics and cosmetics. More speaker information will be updated closer to the event.
Conference Sessions
3 December 2025
Morning Session:Cosmetic Technology: The Intersection of Science and Beauty
Afternoon Session:Biomedical Science and Medicinal Chemistry: Pioneering Solutions for Modern Healthcare
4 December 2025
Morning Session:Innovations in Pharmaceutical Technology: Shaping the Future of Drug Development
Afternoon Session:Pharmaceutical Analysis: Unlocking Insights for Enhanced Efficacy and Safety
Sponsors
Platinum Sponsor
Gold Sponsors
Silver Sponsors
Bronze Sponsor
Contact Information
For more information or inquiries, please contact:
Stay updated with the latest conference news and announcements by following us on Monash Pharmacy social media:
Explore Malaysia
While attending the conference, take the opportunity to explore some of Malaysia’s most iconic tourist attractions, located just a short distance from Monash University Malaysia.
1. Sunway Lagoon Theme Park
Located in Sunway City, just a 15-minute walking from Monash University Malaysia, Sunway Lagoon is one of Malaysia’s most popular theme parks. It offers a wide range of attractions, including water parks, amusement rides, wildlife encounters, and thrilling adventure zones. Whether you’re traveling with family or looking for some fun after the conference, Sunway Lagoon is a must-visit destination.
2. Petronas Twin Towers at KLCC
The Petronas Twin Towers in Kuala Lumpur City Centre (KLCC) are among the tallest twin towers in the world and a symbol of Malaysia’s modernity. Visitors can enjoy the breath-taking view from the Skybridge or the observation deck on the 86th floor. The surrounding KLCC Park and Suria KLCC Mall offer shopping, dining, and entertainment options, making it a perfect spot for relaxation and exploration.
Important Note: Due to the high demand and limited availability, it is highly advisable to book your tickets for the Skybridge and observation deck in advance. Tickets are often sold out on the spot, and pre-booking ensures you won’t miss the chance to experience one of Kuala Lumpur’s most iconic landmarks. You can book your tickets online through the official Petronas Twin Towers website or authorised ticketing platforms.
